SCTX

SCRIBE THERAPEUTICS INC

• Benzinga·4d ago

  Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

• Benzinga·09/30 17:06

  12 Health Care Stocks Moving In Wednesday's Intraday Session

• Seeking Alpha·09/28 11:30

  Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike

• Seeking Alpha·09/27 12:30

  Scribe Surges On IPO Debut -- But All Eyes Turn To 1H27 Data

• TipRanks·09/24 00:20

  Cathie Wood’s ARK Investment buys 143.3K shares of Scribe Therapeutics today

• Benzinga·09/22 14:40

  Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

• Benzinga·09/22 12:06

  12 Health Care Stocks Moving In Tuesday's Pre-Market Session

• Seeking Alpha·09/21 11:05

  Cathie Wood's weekly recap: buys $25M of CoreWeave, trims $40M in Bitcoin ETF

• Seeking Alpha·09/14 11:10

  Cathie Wood's Ark weekly recap: buys Meta, gene-editing stocks while cutting Alphabet

• TipRanks·09/08 10:20

  Wall Street Analysts Are Bullish on Top NA Picks

• Seeking Alpha·09/07 11:10

  Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI

• Dow Jones·09/03 11:24

  Scribe Therapeutics Inc Price Target Maintained With a $60.00/Share by HC Wainwright & Co.

• Benzinga·09/03 11:14

  HC Wainwright & Co. Reiterates Buy on Scribe Therapeutics, Maintains $60 Price Target

• TipRanks·09/03 10:15

  Kapoor Reiterates Buy on Scribe, Maintaining $60 Price Target Ahead of Key STX-1150 Clinical Milestones

• NASDAQ·09/03 07:48

  Scribe Reports Narrower Loss In Q2 Due To Lower Expenses